Cantor Fitzgerald analyst Ross Osborn reiterated a Buy rating on Cerus (CERS – Research Report) yesterday and set a price target of $4.00. The company’s shares closed yesterday at $1.74.

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of its next-generation LED-based illumination device, or the INT200, for the INTERCEPT Blood ...

CONCORD, Calif. (AP) — CONCORD, Calif. (AP) — Cerus Corp. (CERS) on Thursday reported a loss of $2.5 million in its fourth quarter. On a per-share basis, the Concord, California-based company ...

Good day, ladies and gentlemen. Thank you for standing by. And welcome to Cerus Corporation Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] Please be advised ...

Regulatory Approval Allows Company to Initiate Commercialization of the Illumination Device throughout the European Union Cerus Corporation (Nasdaq: CERS) announced today the CE mark approval of ...

Cerus (CERS) expects full-year 2025 product revenue will be in the range of $194 million to $200 million, reflecting 8% to 11% growth from 2024. Included in this range is full-year 2025 IFC ...

CONCORD, Calif., February 19, 2025--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that members of Cerus’ management are scheduled to present at the TD Cowen 45th Annual ...

Cerus Corporation closed 2024 with strong momentum, driven by double-digit product revenue growth and positive adjusted EBITDA. The company is targeting 8%-11% revenue growth in 2025, supported by ...